Missing Elements in the Public Science Supporting the COVID-19 Spread Narrative in the US

Dr James L. Sherley, is a physician scientist and bioentrepreneur who currently serves as the President and CEO of stem cell biotechnology company Asymmetrex, LLC. He holds joint MD and PhD degrees in Medicine and Cellular and Molecular Biology and Genetics. His graduate research was conducted in a molecular virology laboratory. Before starting his professional career in biomedical research, he trained as a Postdoctoral Fellow at Princeton University, with cancer cell molecular biology as the area of specification. In 1998, Dr Sherley moved to a faculty appointment at Massachusetts Institute of Technology in Cambridge, MA, before working as a Senior Scientist at the Boston Biomedical Research Institute. Throughout his professional career, Dr Sherley has served on numerous scientific advisory boards, including serving as the Chair for the Meharry-Vanderbilt National Institutes of Health U54 Cancer Health Disparities Partnership Program Steering Committee and as a member of the National Institute of Environmental Health Sciences National Toxicology Program Board of Scientific Counselors. He also actively contributes scholarly articles on bioethics issues in science, medicine, and society.